Using a promiscuous inhibitor to uncover cancer drug targets

(American Society for Biochemistry and Molecular Biology) Scientists at Harvard Medical School and the Dana-Farber Cancer Institute have developed a method that exploits the multitargeted nature of a chemical inhibitor to pinpoint vulnerabilities within cancer cells.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news